Easier, more supportive methadone clinic care
Methadone Patient Access to Collaborative Treatment (MPACT)
This project partners with methadone clinics to change staff practices so patients can get more flexible, trauma‑informed care like take‑home doses and telehealth.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11358201 on NIH RePORTER |
What this research studies
You may see clinic staff trained to use trauma‑informed approaches and to change routines that feel punitive or 'carceral.' The team will work directly with opioid treatment programs to pilot the MPACT practice‑change intervention and support staff in addressing their own work‑related trauma and beliefs. The goal is to make concrete changes such as multi‑day dosing, fewer routine urine tests for stable patients, and more telehealth options that help rural or homebound patients. The project will track whether these changes reduce treatment interruptions and relapse and can be sustained at participating clinics.
Who could benefit from this research
Good fit: People receiving methadone maintenance at participating opioid treatment programs, especially those who need take‑home dosing, live in rural areas, or have trouble attending daily visits.
Not a fit: People not enrolled in methadone programs (for example those on buprenorphine only) or those unable to attend participating clinics are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, clinics may keep more people in methadone treatment and reduce relapses and overdoses by making care more flexible and supportive.
How similar studies have performed: Earlier COVID‑era policy flexibilities gave temporary examples of more flexible care but did not produce widespread lasting change, so this intervention builds on limited prior experience and is partly novel.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Meyerson, Beth — University of Arizona
- Study coordinator: Meyerson, Beth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.